By proceeding, you agree to our Terms of Use and Privacy Policy.
Synaffix BV is a biotech company that has established a proprietary, clinical-stage antibody-drug conjugate (ADC) technology platform that delivers best-in-class ADCs (safety and efficacy). Our platform is commercially validated by well over $1.
24-26 May 2022
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.
Event Ended
USA
Paid
Boston
06-09 September 2022
3 years since we last brought the community together in-person in San Diego we are excited to once more unite 600+ ADC enthusiasts at the World’s Definitive Antibody-Drug Conjugate Event.
San Diego
25-27 April 2023
Welcome to the 5th Annual Cell Engager Summit! Tecytinib’s approval last year has strongly fuelled the mentality that this is the year of cell engager! Bispecifics have led the way and liquid tumors have been hit hard. Now Immunocore and others are s
16-19 October 2023
Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the ea